2023
DOI: 10.1016/j.jbc.2022.102821
|View full text |Cite
|
Sign up to set email alerts
|

Neurodegeneration risk factor, EIF2AK3 (PERK), influences tau protein aggregation

Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
10
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 11 publications
(15 citation statements)
references
References 71 publications
3
10
0
Order By: Relevance
“…Here, we extended these investigations to identify additional potential pLoF PERK disease variants. We confirmed previous racial and ethnic disparities in PERK Haplotype B frequency at 4 individual SNPs [12] . Through three-dimensional structural modeling, we reveal how another tauopathy PERK variant, R240H, can induce structural shifts in PERK dimerization and tetramerization.…”
Section: Discussionsupporting
confidence: 89%
See 3 more Smart Citations
“…Here, we extended these investigations to identify additional potential pLoF PERK disease variants. We confirmed previous racial and ethnic disparities in PERK Haplotype B frequency at 4 individual SNPs [12] . Through three-dimensional structural modeling, we reveal how another tauopathy PERK variant, R240H, can induce structural shifts in PERK dimerization and tetramerization.…”
Section: Discussionsupporting
confidence: 89%
“…Structural modeling of tauopathy-linked PERK variants indicated that Haplotype B and the R240H polymorphisms disrupted crucial hydrogen bonds in the luminal domain, potentially altering PERK’s function and stability. Our data supports that many tauopathy-linked PERK variants carry an altered stress-sensing luminal domain but preserved kinase function[12].…”
Section: Introductionsupporting
confidence: 85%
See 2 more Smart Citations
“…Loss-of-function mutations in EIF2AK3 , the gene that encodes PERK, are causatively associated with Wolcott-Rallison syndrome – a rare autosomal-recessive disorder that involves multi-organ failures including prominent neonatal or early-childhood insulin-dependent diabetes, kidney and liver dysfunction, and cardiac abnormalities (Delepine et al , 2000; Julier & Nicolino, 2010; Mann et al , 2022). Hypomorphic EIF2AK3 alleles are also implicated in neurodegenerative diseases including the tauopathy progressive supranuclear palsy (PSP) (Hoglinger et al , 2011; Park et al , 2022; Yuan et al , 2018). Further, deficiencies in PERK signaling have been implicated in the pathogenesis of many diseases including PSP and Huntington’s disease (HD) (Almeida et al ., 2022; Bruch et al , 2017; Ganz et al , 2020; Shacham et al , 2021).…”
Section: Introductionmentioning
confidence: 99%